Tags

Type your tag names separated by a space and hit enter

Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations.
J Gastroenterol Hepatol. 2014 Dec; 29(12):1954-62.JG

Abstract

This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF.

Authors+Show Affiliations

Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Parkville, Melbourne, Victoria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25238538

Citation

Ledder, Oren, et al. "Cystic Fibrosis: an Update for Clinicians. Part 2: Hepatobiliary and Pancreatic Manifestations." Journal of Gastroenterology and Hepatology, vol. 29, no. 12, 2014, pp. 1954-62.
Ledder O, Haller W, Couper RT, et al. Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. J Gastroenterol Hepatol. 2014;29(12):1954-62.
Ledder, O., Haller, W., Couper, R. T., Lewindon, P., & Oliver, M. (2014). Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. Journal of Gastroenterology and Hepatology, 29(12), 1954-62. https://doi.org/10.1111/jgh.12785
Ledder O, et al. Cystic Fibrosis: an Update for Clinicians. Part 2: Hepatobiliary and Pancreatic Manifestations. J Gastroenterol Hepatol. 2014;29(12):1954-62. PubMed PMID: 25238538.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. AU - Ledder,Oren, AU - Haller,Wolfram, AU - Couper,Richard Tl, AU - Lewindon,Peter, AU - Oliver,Mark, PY - 2014/08/20/accepted PY - 2014/9/20/entrez PY - 2014/9/23/pubmed PY - 2015/8/11/medline KW - cirrhosis KW - cystic fibrosis KW - liver KW - nutrition KW - pancreas KW - pancreatic enzymes SP - 1954 EP - 62 JF - Journal of gastroenterology and hepatology JO - J. Gastroenterol. Hepatol. VL - 29 IS - 12 N2 - This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF. SN - 1440-1746 UR - https://www.unboundmedicine.com/medline/citation/25238538/Cystic_fibrosis:_an_update_for_clinicians__Part_2:_hepatobiliary_and_pancreatic_manifestations_ L2 - https://doi.org/10.1111/jgh.12785 DB - PRIME DP - Unbound Medicine ER -